Comparative evaluation of the caesarean section rate in term nulliparas with labour dystocia following augmentation with oxytocin alone versus with oxytocin and drotaverine

Background: Labour dystocia is the commonest indication for emergency caesarean section in nulliparas, and occurs when progress of labour abnormally slow. may be caused by abnormalities uterine contractions, slow cervical dilatation, or mechanical disproportion between foetal presenting part maternal pelvis. Augmentation with oxytocin traditional management as it enhances contractions. At times, despite good persists due to smooth muscle spasms factors, thereby increasing rate. Drotaverine a musculotropic antispasmodic can relieve spasms. Aim/objective: This study compared rate term nulliparas that were augmented placebo versus drotaverine Methods: was single-blinded randomized clinical trial conducted January August 2021. It involved 156 nulliparous women into two groups augmentation labour. Each group had 78 parturients managed either drotaverine. They monitored till delivery both compared. Data obtained analysed SPSS version 23 software. The level significance set at 0.05, P< 0.05 statistically significant. Results: similar their sociodemographic characteristics. In this 21(13.5%) while 135(86.5%) vaginal following augmentation. oxytocin-placebo oxytocin-drotaverine (10 (12.8%) vs 11 (14.1%), p=0.82). majority, 14 (67%) sections 4 (19%) functional 3(14%) distress. Conclusion: use managing did not improve majority cases dystocia.